Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
The directors said the decision comes after months of work that failed to result in an actionable plan that meets the ...
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki ...